Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.2B | 9.4B | 8.9B | 7.9B |
Cost of revenue | 2.4B | 2.4B | 2.4B | 2.3B |
Gross profit | 7.8B | 7.1B | 6.5B | 5.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.8B | 1.7B | 1.6B | 1.5B |
Operating income | 2.4B | 1.7B | 1.3B | 662M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 159M | 124M | 131M | 117M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 1.8B | 1.4B | 1.0B |
Tax provision | 572M | 497M | 312M | 256M |
Net income | 1.8B | 1.3B | 1.1B | 757M |
Basic EPS | — | 3.3 | 2.6 | 1.9 |
Diluted EPS | — | 3.3 | 2.6 | 1.9 |
Basic average shares | — | 400.9M | 401.9M | 400.5M |
Diluted average shares | — | 402.1M | 401.9M | 402.7M |
EBITDA | 3.6B | 3.0B | 2.6B | 1.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |